Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kepley BioSystems offers ocean restorative technology to help stem the continued depletion of wild fish.
InnAVasc Medical is a medical device company that designs and develops products for vascular access for hemodialysis.
Enzerna Biosciences is a pre-clinical stage company.
Atlantic Fish Company focuses on developing cultivated seafood via cellular agriculture.
InSoma Bio integrates biology and materials science to solve problems in tissue engineering and regenerative medicine.
Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.
NabGen, Inc. is an NC based biotech company developing an antibody suppression platform with broad applications.
IngateyGen is a biotech company that concentrates on human nutrition.
BiomedInnovations are developing technologies for long-term storage and interaction with large tissues and organs outside of the human body.
The digestive health platform of the future
QATCH Technologies company that’s developing a tool to determine the injectability and manufacturability of biopharmaceutical products.
Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine.
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.
Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia.
Renaissance Fiber produces high quality textile and technical fibers and yarns manufactured from industrial hemp.
Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.
Isolere Bio is a Healthcare Company provides manufacturing solutions,facilitate therapeutic developments.
Lindy Biosciences is a development-stage protein therapeutic formulations company.
Advanced Chemotherapy Technologies is a startup developing a device that can infuse chemotherapies into poorly vascularized tumors.
EncepHeal Therapeutics enhances the development of first-in-class medicines to improve treatment of mental health disorders.
RainBio, a pioneer in ocular gene therapy, focuses on corneal blindness.
CasTag Biosciences specializes in cell biology and regenerative medicine, focusing on revolutionizing the speed of endogenously.
Redbud Labs develops and manufactures MEMS and microfluidics technologies for the life science industry.
Higgs Boson is a health care company.
North Carolina Biotechnology Center has invested in 57 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
North Carolina Biotechnology Center's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Belhaven Biopharma received $10.0M in a Series A round. North Carolina Biotechnology Center's total known invested capital is $145.1M.
North Carolina Biotechnology Center's average investment size is $2.8M across its portfolio of 57 companies.
Recent North Carolina Biotechnology Center portfolio additions include Kepley BioSystems, InnAVasc Medical, Enzerna, Atlantic Fish Company, inSomaBio. These companies were founded in 2020 or later.